| Selective A2A receptor antagonist prevents microglia-mediated neuroinflammation and protects retinal ganglion cells from high intraocular pressure–induced transient ischemic injury MH Madeira, R Boia, F Elvas, T Martins, RA Cunha, AF Ambrósio, ... Translational research 169, 112-128, 2016 | 86 | 2016 |
| Adenosine A2AR blockade prevents neuroinflammation-induced death of retinal ganglion cells caused by elevated pressure MH Madeira, F Elvas, R Boia, FQ Gonçalves, RA Cunha, AF Ambrósio, ... Journal of neuroinflammation 12, 1-13, 2015 | 81 | 2015 |
| Targeting fibroblast activation protein (FAP): next generation PET radiotracers using squaramide coupled bifunctional DOTA and DATA5m chelators ES Moon, F Elvas, G Vliegen, S De Lombaerde, C Vangestel, ... EJNMMI radiopharmacy and chemistry 5, 1-20, 2020 | 79 | 2020 |
| Neuropeptide Y receptors activation protects rat retinal neural cells against necrotic and apoptotic cell death induced by glutamate A Santos-Carvalho, F Elvas, AR Alvaro, AF Ambrósio, C Cavadas Cell death & disease 4 (5), e636-e636, 2013 | 70 | 2013 |
| Molecular imaging of apoptosis: the case of caspase-3 radiotracers L Beroske, T Van den Wyngaert, S Stroobants, P Van der Veken, F Elvas International journal of molecular sciences 22 (8), 3948, 2021 | 67 | 2021 |
| Treatment with A2A receptor antagonist KW6002 and caffeine intake regulate microglia reactivity and protect retina against transient ischemic damage R Boia, F Elvas, MH Madeira, ID Aires, AC Rodrigues-Neves, P Tralhão, ... Cell death & disease 8 (10), e3065-e3065, 2017 | 62 | 2017 |
| SPECT/CT: Standing on the shoulders of giants, it is time to reach for the sky! T Van den Wyngaert, F Elvas, S De Schepper, JA Kennedy, O Israel Journal of Nuclear Medicine 61 (9), 1284-1291, 2020 | 58 | 2020 |
| Adenosine A3 receptor activation is neuroprotective against retinal neurodegeneration J Galvao, F Elvas, T Martins, MF Cordeiro, AF Ambrósio, AR Santiago Experimental eye research 140, 65-74, 2015 | 57 | 2015 |
| Diabetes alters KIF1A and KIF5B motor proteins in the hippocampus FI Baptista, MJ Pinto, F Elvas, RD Almeida, AF Ambrosio PloS one 8 (6), e65515, 2013 | 51 | 2013 |
| Characterization of [99mTc]Duramycin as a SPECT Imaging Agent for Early Assessment of Tumor Apoptosis F Elvas, C Vangestel, S Rapic, J Verhaeghe, B Gray, K Pak, S Stroobants, ... Molecular imaging and biology 17, 838-847, 2015 | 49 | 2015 |
| Phosphatidylethanolamine targeting for cell death imaging in early treatment response evaluation and disease diagnosis F Elvas, S Stroobants, L Wyffels Apoptosis 22, 971-987, 2017 | 46 | 2017 |
| 99mTc-Duramycin SPECT imaging of early tumor response to targeted therapy: a comparison with 18F-FDG PET F Elvas, J Boddaert, C Vangestel, K Pak, B Gray, S Kumar-Singh, ... Journal of Nuclear Medicine 58 (4), 665-670, 2017 | 45 | 2017 |
| Development of antibody immuno-PET/SPECT radiopharmaceuticals for imaging of oncological disorders—an update J Dewulf, K Adhikari, C Vangestel, TVD Wyngaert, F Elvas Cancers 12 (7), 1868, 2020 | 40 | 2020 |
| Early prediction of tumor response to treatment: preclinical validation of 99mTc-duramycin F Elvas, C Vangestel, K Pak, P Vermeulen, B Gray, S Stroobants, ... Journal of Nuclear Medicine 57 (5), 805-811, 2016 | 34 | 2016 |
| Activation of Neuropeptide Y Receptors Modulates Retinal Ganglion Cell Physiology and Exerts Neuroprotective Actions In Vitro J Martins, F Elvas, D Brudzewsky, T Martins, B Kolomiets, P Tralhão, ... ASN neuro 7 (4), 1759091415598292, 2015 | 32 | 2015 |
| Diabetes induces changes in KIF1A, KIF5B and dynein distribution in the rat retina: implications for axonal transport FI Baptista, MJ Pinto, F Elvas, T Martins, RD Almeida, AF Ambrósio Experimental eye research 127, 91-103, 2014 | 32 | 2014 |
| Neuropeptide Y receptors Y1 and Y2 are present in neurons and glial cells in rat retinal cells in culture A Santos-Carvalho, CA Aveleira, F Elvas, AF Ambrósio, C Cavadas Investigative ophthalmology & visual science 54 (1), 429-443, 2013 | 29 | 2013 |
| Evaluation of [18F]CP18 as a Substrate-Based Apoptosis Imaging Agent for the Assessment of Early Treatment Response in Oncology S Rapic, C Vangestel, F Elvas, J Verhaeghe, TV den Wyngaert, L Wyffels, ... Molecular Imaging and Biology 19, 560-569, 2017 | 25 | 2017 |
| Caspase-3 probes for PET imaging of apoptotic tumor response to anticancer therapy F Elvas, TV Berghe, Y Adriaenssens, P Vandenabeele, K Augustyns, ... Organic & biomolecular chemistry 17 (19), 4801-4824, 2019 | 21 | 2019 |
| Improved stability of a novel fluorine-18 labeled TCO analogue for pretargeted PET imaging E Ruivo, K Adhikari, F Elvas, J Fissers, C Vangestel, S Staelens, ... Nuclear medicine and biology 76, 36-42, 2019 | 20 | 2019 |
